NASDAQ:SRPT   Sarepta Therapeutics, Inc.
This stock had a stock split without splitting it split about 50% due to bad earnings...it has now found support on the 200 dma. This offers a good entry should you take the risk to buy here. However it may be best to wait until it breaks out to the upside or downside to take a trade long/short. The potential on breakout to upside is back to the 40s could take months but would be a double from here,

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.